Cell Growth & Differentiation, Vol 4, Issue 8 657-663, Copyright © 1993 by American Association of Cancer Research

ARTICLES

Resistance to phorbol ester-induced differentiation of a U-937 myeloid leukemia cell variant with a signaling defect upstream to Raf-1 kinase

R Hass, M Hirano, S Kharbanda, E Rubin, G Meinhardt and D Kufe
Laboratory of Clinical Pharmacology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115.

Previous studies have demonstrated that treatment of human U-937 myeloid leukemia cells with 12-O-tetradecanoylphorbol-13-acetate (TPA) is associated with growth arrest and induction of monocytic differentiation. The present work describes the isolation of a U-937 cell variant, designated TUR, which is unresponsive to the growth-inhibitory effects of this agent. The results demonstrate that, in contrast to U-937 cells, the TUR line fails to respond to TPA with induction of the c-jun, junB, c-fos, and EGR-1 early response genes. The finding that these cells also fail to exhibit adherence or induction of the tumor necrosis factor and c-fms genes further supports their resistance to TPA-induced differentiation. In contrast, TUR cells responded to 1,25-dihydroxyvitamin D3, another inducer of monocytic differentiation, with growth arrest and induction of early response gene and c-fms transcripts. TUR cells also responded to okadaic acid, an inhibitor of type 1 and 2A protein phosphatases, with similar changes in gene expression. Further characterization of TUR cells has demonstrated decreased expression of protein kinase C as compared to wild-type U-937 cells. We also demonstrate that although treatment of U-937 cells with TPA is associated with activation of the Raf-1 serine/threonine kinase, there was no detectable decrease in electrophoretic mobility of this protein in TPA-treated TUR cells. Taken together, these findings indicate that the TUR variant is defective in TPA-induced signaling events upstream to activation of Raf-1 kinase.

This article has been cited by other articles:

				C. Grant, P. Jain, M. Nonnemacher, K. E. Flaig, B. Irish, J. Ahuja, A. Alexaki, T. Alefantis, and B. Wigdahl AP-1-directed human T cell leukemia virus type 1 viral gene expression during monocytic differentiation J. Leukoc. Biol., September 1, 2006; 80(3): 640 - 650. [Abstract] [Full Text] [PDF]

				B. A. Hug, N. Ahmed, J. A. Robbins, and M. A. Lazar A Chromatin Immunoprecipitation Screen Reveals Protein Kinase C{beta} as a Direct RUNX1 Target Gene J. Biol. Chem., January 9, 2004; 279(2): 825 - 830. [Abstract] [Full Text] [PDF]

				O. Ciftci, O. Ullrich, C. A. Schmidt, A. Diestel, and R. Hass Regulation of the nuclear proteasome activity in myelomonocytic human leukemia cells after adriamycin treatment Blood, May 1, 2001; 97(9): 2830 - 2838. [Abstract] [Full Text] [PDF]

				M. Kaneki, S. Kharbanda, P. Pandey, K. Yoshida, M. Takekawa, J.-R. Liou, R. Stone, and D. Kufe Functional Role for Protein Kinase Cbeta as a Regulator of Stress-Activated Protein Kinase Activation and Monocytic Differentiation of Myeloid Leukemia Cells Mol. Cell. Biol., January 1, 1999; 19(1): 461 - 470. [Abstract] [Full Text] [PDF]

				J. A. Lopez-Guerrero, B. Rayet, M. Tuynder, J. Rommelaere, and C. Dinsart Constitutive Activation of U937 Promonocytic Cell Clones Selected for Their Resistance to Parvovirus H-1 Infection Blood, March 1, 1997; 89(5): 1642 - 1653. [Abstract] [Full Text] [PDF]

				D. M. Berry, R. Antochi, M. Bhatia, and K. A. Meckling-Gill 1,25-Dihydroxyvitamin D3 Stimulates Expression and Translocation of Protein Kinase Calpha and Cdelta via a Nongenomic Mechanism and Rapidly Induces Phosphorylation of a 33-kDa Protein in Acute Promyelocytic NB4 Cells J. Biol. Chem., July 5, 1996; 271(27): 16090 - 16096. [Abstract] [Full Text] [PDF]

				R. Datta, K. Yoshinaga, M. Kaneki, P. Pandey, and D. Kufe Phorbol Ester-induced Generation of Reactive Oxygen Species Is Protein Kinase Cbeta -dependent and Required for SAPK Activation J. Biol. Chem., December 22, 2000; 275(52): 41000 - 41003. [Abstract] [Full Text] [PDF]